122 related articles for article (PubMed ID: 18782500)
21. Optimization and validation of small quantity RNA profiling for identifying TNF responses in cultured human vascular endothelial cells.
Shou J; Qian HR; Lin X; Stewart T; Onyia JE; Gelbert LM
J Pharmacol Toxicol Methods; 2006; 53(2):152-9. PubMed ID: 15878830
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?
Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K
Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761
[TBL] [Abstract][Full Text] [Related]
23. [A primary study on the ARP-SRP gene expression profiling of brain injury by cDNA microarray].
Zhou YW; Zhang YG; Deng WN
Fa Yi Xue Za Zhi; 2002 Aug; 18(3):146-9. PubMed ID: 12608292
[TBL] [Abstract][Full Text] [Related]
24. Messenger RNA expression profiling using DNA microarray technology: diagnostic tool, scientific analysis or un-interpretable data?
Walker MS; Hughes TA
Int J Mol Med; 2008 Jan; 21(1):13-7. PubMed ID: 18097611
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma.
Haque T; Faury D; Albrecht S; Lopez-Aguilar E; Hauser P; Garami M; Hanzély Z; Bognár L; Del Maestro RF; Atkinson J; Nantel A; Jabado N
Clin Cancer Res; 2007 Nov; 13(21):6284-92. PubMed ID: 17975139
[TBL] [Abstract][Full Text] [Related]
26. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review.
Minagar A; Shapshak P; Duran EM; Kablinger AS; Alexander JS; Kelley RE; Seth R; Kazic T
J Neurol Sci; 2004 Sep; 224(1-2):3-17. PubMed ID: 15450765
[TBL] [Abstract][Full Text] [Related]
27. MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a.
Aung LL; Mouradian MM; Dhib-Jalbut S; Balashov KE
J Neuroimmunol; 2015 Jan; 278():185-9. PubMed ID: 25468268
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomics: mRNA and alternative splicing.
Sánchez-Pla A; Reverter F; Ruíz de Villa MC; Comabella M
J Neuroimmunol; 2012 Jul; 248(1-2):23-31. PubMed ID: 22626445
[TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis genetics.
McElroy JP; Oksenberg JR
Curr Top Microbiol Immunol; 2008; 318():45-72. PubMed ID: 18219814
[TBL] [Abstract][Full Text] [Related]
30. Large-scale gene-expression studies and the challenge of multiple sclerosis.
Baranzini SE; Hauser SL
Genome Biol; 2002 Sep; 3(10):reviews1027. PubMed ID: 12372148
[TBL] [Abstract][Full Text] [Related]
31. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment.
Schwartz DR; Moin K; Yao B; Matrisian LM; Coussens LM; Bugge TH; Fingleton B; Acuff HB; Sinnamon M; Nassar H; Platts AE; Krawetz SA; Linebaugh BE; Sloane BF
Mol Cancer Res; 2007 May; 5(5):443-54. PubMed ID: 17510311
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
[TBL] [Abstract][Full Text] [Related]
33. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.
Satoh J; Nakanishi M; Koike F; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T
Neurobiol Dis; 2005 Apr; 18(3):537-50. PubMed ID: 15755681
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions.
Satoh J; Obayashi S; Misawa T; Tabunoki H; Yamamura T; Arima K; Konno H
Neuropathology; 2008 Dec; 28(6):561-76. PubMed ID: 18410276
[TBL] [Abstract][Full Text] [Related]
35. Methodological considerations for gene expression profiling of human brain.
Atz M; Walsh D; Cartagena P; Li J; Evans S; Choudary P; Overman K; Stein R; Tomita H; Potkin S; Myers R; Watson SJ; Jones EG; Akil H; Bunney WE; Vawter MP;
J Neurosci Methods; 2007 Jul; 163(2):295-309. PubMed ID: 17512057
[TBL] [Abstract][Full Text] [Related]
36. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
[TBL] [Abstract][Full Text] [Related]
37. Effects of RNA degradation on gene expression analysis of human postmortem tissues.
Lee J; Hever A; Willhite D; Zlotnik A; Hevezi P
FASEB J; 2005 Aug; 19(10):1356-8. PubMed ID: 15955843
[TBL] [Abstract][Full Text] [Related]
38. Exploiting genotypic differences to identify genes important for EAE development.
Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S
J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174
[TBL] [Abstract][Full Text] [Related]
39. Expression profiling of glycosyltransferases and related enzymes using gene microarrays.
Hammond JA; Head SR
Methods Enzymol; 2006; 416():141-56. PubMed ID: 17113865
[TBL] [Abstract][Full Text] [Related]
40. Extraction and proteomic analysis of proteins from normal and multiple sclerosis postmortem brain.
Newcombe J; Eriksson B; Ottervald J; Yang Y; Franzén B
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):191-202. PubMed ID: 15652809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
